r.solberg
Submits third-party assay reports on material purchased directly. Based in Nairobi.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.37%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043492 | MOTS-c | BCH | BCH-2601-U5146 | Kestrel | 2026-Q1 | 98.38 | 5.93 | 88.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019919 | Ipamorelin | HJ | HJ-2504-X6056 | Janoshik | 2025-Q3 | 99.80 | 6.37 | 91.1 | Buyer-sourced | 0 | PASS |
| AX-2025-019051 | Thymosin α1 | ASY | ASY-{CAT}-2031 | PeptideMeter | 2025-Q2 | 99.37 | 4.20 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018644 | Tirzepatide | QSC | QSC-2408-T5296 | Medutest | 2025-Q1 | 99.74 | 6.51 | 91.7 | Laboratory-retained | 0 | PASS |
| AX-2025-018764 | BPC-157 | QSC | QSC-2412-D7527 | Janoshik | 2025-Q1 | 99.33 | 6.68 | 93.4 | Buyer-sourced | 0 | PASS |
| AX-2024-004144 | Retatrutide | WWB | WWB-2408-X2078 | VendorInvestigate | 2024-Q4 | 99.57 | 5.93 | 105.9 | Buyer-sourced | 0 | PASS |
| AX-2024-005243 | MK-677 (Ibutamoren mesylate) | WXT | WXT-2408-P3767 | Nordanalyt | 2024-Q4 | 99.11 | 4.94 | 94.4 | Buyer-sourced | 1 | FAIL |
| AX-2024-004267 | Retatrutide | QYB | QYB-2312-K4892 | Kestrel | 2024-Q2 | 99.36 | 5.57 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004901 | BPC-157 | ERP | ERP-2402-D9383 | Janoshik | 2024-Q2 | 99.76 | 6.26 | 106.1 | Buyer-sourced | 0 | PASS |